Symbols / CDT Stock $0.74 -4.26% CDT Equity Inc.

Healthcare • Biotechnology • United States • NCM
CDT (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Dr. Andrew Regan
Exch · Country NCM · United States
Market Cap 3.60M
Enterprise Value 2.87M
Income -39.22M
Sales —
FCF (ttm) 5.22M
Book/sh -77.82
Cash/sh 0.31
Employees 4
Insider 10d —
IPO Mar 28, 2022
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E —
PEG —
P/S —
P/B -0.01
P/C —
EV/EBITDA -0.12
EV/Sales —
Quick Ratio 0.12
Current Ratio 0.34
Debt/Eq —
LT Debt/Eq —
EPS (ttm) -1,175.15
EPS next Y —
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2025-11-12
Earnings (prior) 2025-11-12
ROA -3.45%
ROE —
ROIC —
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand 4.86M
Shs Float 2.26M
Insider Own 77.66%
Instit Own 0.00%
Short Float 2.10%
Short Ratio 0.02
Short Interest 53.54K
52W High 610.00
vs 52W High -99.88%
52W Low 0.69
vs 52W Low 8.16%
Beta 1.41
Impl. Vol. —
Rel Volume 0.22
Avg Volume 942.67K
Volume 206.33K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $0.78
Price $0.74
Change -4.26%
About

CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company's pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto's thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It also provides treatments for inflammatory disorders, oncology, dermatology, rare diseases and animal health. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.74
Latest analyst target
3. DCF / Fair value
$19.34
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.74
Low
—
High
—
Mean
—
News
RSS: Latest CDT news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2024-08-08 Vela Technologies PLC — — 0 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
36.66
+142.70%
15.11
+187.06%
5.26
+66.52%
3.16
Research And Development
5.05
+49.62%
3.38
+3653.33%
0.09
-18.92%
0.11
Selling General And Administration
31.70
+163.29%
12.04
+132.81%
5.17
+69.63%
3.05
General And Administrative Expense
31.70
+163.29%
12.04
+132.81%
5.17
+69.63%
3.05
Other Gand A
31.70
+163.29%
12.04
+132.81%
5.17
+69.63%
3.05
Total Expenses
36.66
+142.70%
15.11
+187.06%
5.26
+66.52%
3.16
Operating Income
-36.66
-142.70%
-15.11
-187.06%
-5.26
-66.52%
-3.16
Total Operating Income As Reported
-36.76
-138.39%
-15.42
-193.03%
-5.26
-66.52%
-3.16
EBITDA
-36.48
-130.32%
-15.84
-618.80%
3.05
+162.47%
-4.89
Normalized EBITDA
-36.88
-140.42%
-15.34
-298.75%
-3.85
-12.32%
-3.42
Reconciled Depreciation
2.42
+430.63%
0.46
0.00
—
EBIT
-38.91
-138.74%
-16.30
-633.77%
3.05
+162.47%
-4.89
Total Unusual Items
0.40
+180.16%
-0.50
-107.23%
6.90
+571.96%
-1.46
Total Unusual Items Excluding Goodwill
0.40
+180.16%
-0.50
-107.23%
6.90
+571.96%
-1.46
Special Income Charges
0.25
+134.84%
-0.71
—
—
Other Special Charges
-0.65
-191.93%
0.71
—
—
Net Income
-39.22
-120.33%
-17.80
-3227.48%
-0.54
+89.05%
-4.89
Pretax Income
-39.22
-120.33%
-17.80
-726.39%
2.84
+158.15%
-4.89
Net Non Operating Interest Income Expense
-0.29
+80.51%
-1.49
-661.73%
-0.20
0.00
Interest Expense Non Operating
0.32
-78.82%
1.51
+613.74%
0.21
0.00
Net Interest Income
-0.29
+80.51%
-1.49
-661.73%
-0.20
0.00
Interest Expense
0.32
-78.82%
1.51
+613.74%
0.21
0.00
Interest Income Non Operating
0.03
+115.38%
0.01
-13.33%
0.01
0.00
Interest Income
0.03
+115.38%
0.01
-13.33%
0.01
0.00
Other Income Expense
-2.27
-88.79%
-1.20
-114.51%
8.30
+580.60%
-1.73
Other Non Operating Income Expenses
-2.67
-279.15%
-0.70
-150.36%
1.40
+628.30%
-0.27
Gain On Sale Of Security
0.15
-25.60%
0.21
-97.00%
6.90
+571.96%
-1.46
Tax Rate For Calcs
0.00
0.00
-100.00%
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
-100.00%
1.45
0.00
Net Income Including Noncontrolling Interests
-39.22
-120.33%
-17.80
-726.39%
2.84
+158.15%
-4.89
Net Income From Continuing Operation Net Minority Interest
-39.22
-120.33%
-17.80
-3227.48%
-0.54
+89.05%
-4.89
Net Income From Continuing And Discontinued Operation
-39.22
-120.33%
-17.80
-3227.48%
-0.54
+89.05%
-4.89
Net Income Continuous Operations
-39.22
-120.33%
-17.80
-726.39%
2.84
+158.15%
-4.89
Normalized Income
-39.62
-129.00%
-17.30
-189.06%
-5.99
-74.77%
-3.42
Net Income Common Stockholders
-39.22
-120.33%
-17.80
-3227.48%
-0.54
+89.05%
-4.89
Diluted EPS
-1,177.89
+96.95%
-38,616.05
-56.86%
-24,617.89
-21.40%
-20,278.01
Basic EPS
-1,177.89
+96.95%
-38,616.05
-1675.62%
-2,174.80
+89.28%
-20,278.01
Basic Average Shares
0.03
+7123.43%
0.00
+87.40%
0.00
+2.07%
0.00
Diluted Average Shares
0.03
+7123.43%
0.00
+87.40%
0.00
+2.07%
0.00
Diluted NI Availto Com Stockholders
-39.22
-120.33%
-17.80
-193.96%
-6.06
-23.92%
-4.89
Average Dilution Earnings
—
0.00
+100.00%
-5.52
—
Gain On Sale Of PPE
-0.40
0.00
—
—
Other Taxes
-0.10
+69.11%
-0.31
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
5.65
+34.75%
4.19
-41.96%
7.22
+144380.00%
0.01
Current Assets
4.38
+61.29%
2.71
-52.64%
5.73
0.00
Cash Cash Equivalents And Short Term Investments
1.51
+172.38%
0.55
-86.90%
4.23
0.00
Cash And Cash Equivalents
1.51
+172.38%
0.55
-86.90%
4.23
0.00
Receivables
—
0.49
0.00
—
Other Receivables
—
0.49
—
—
Prepaid Assets
1.05
+175.53%
0.38
-74.75%
1.50
0.00
Other Current Assets
1.82
+2.36%
1.78
—
—
Total Non Current Assets
1.27
-14.01%
1.48
-0.87%
1.49
+29720.00%
0.01
Net PPE
0.41
+35.64%
0.30
0.00
—
Gross PPE
0.41
+35.64%
0.30
0.00
—
Other Properties
0.41
+35.64%
0.30
—
—
Goodwill And Other Intangible Assets
—
—
0.00
-100.00%
0.01
Other Intangible Assets
—
—
—
0.01
Other Non Current Assets
0.86
-26.81%
1.18
-21.19%
1.49
—
Total Liabilities Net Minority Interest
12.82
+16.69%
10.99
+43.03%
7.68
-23.91%
10.09
Current Liabilities
12.82
+19.36%
10.74
+496.39%
1.80
-56.87%
4.18
Payables And Accrued Expenses
12.04
+255.20%
3.39
+315.56%
0.82
-68.42%
2.58
Payables
1.91
+33.96%
1.43
+564.19%
0.21
—
Accounts Payable
1.91
+33.96%
1.43
+564.19%
0.21
0.00
Current Accrued Expenses
10.13
+416.15%
1.96
+226.62%
0.60
-76.74%
2.58
Current Debt And Capital Lease Obligation
0.78
-89.46%
7.35
+646.19%
0.98
+462.86%
0.17
Current Debt
0.66
-90.87%
7.23
+634.11%
0.98
+462.86%
0.17
Other Current Borrowings
0.66
-90.08%
6.66
+732.00%
0.80
+357.14%
0.17
Current Capital Lease Obligation
0.12
-3.36%
0.12
0.00
—
Other Current Liabilities
—
—
—
1.42
Total Non Current Liabilities Net Minority Interest
0.00
-100.00%
0.24
-95.83%
5.88
-0.64%
5.92
Long Term Debt And Capital Lease Obligation
0.00
-100.00%
0.11
0.00
-100.00%
1.83
Long Term Debt
—
—
—
1.83
Long Term Capital Lease Obligation
0.00
-100.00%
0.11
0.00
—
Tradeand Other Payables Non Current
—
0.00
-100.00%
5.74
0.00
Non Current Deferred Liabilities
—
—
0.00
-100.00%
4.08
Non Current Deferred Revenue
—
—
0.00
-100.00%
4.08
Stockholders Equity
-7.17
-5.55%
-6.79
-1386.43%
-0.46
+95.47%
-10.09
Common Stock Equity
-7.17
-5.55%
-6.79
-1386.43%
-0.46
+95.47%
-10.09
Capital Stock
0.00
0.00
-100.00%
0.01
+16.67%
0.01
Common Stock
0.00
0.00
-100.00%
0.01
+16.67%
0.01
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
0.09
+19886.98%
0.00
+87.40%
0.00
+2.07%
0.00
Ordinary Shares Number
0.09
+19886.98%
0.00
+87.40%
0.00
+2.07%
0.00
Additional Paid In Capital
61.17
+179.40%
21.89
+110.03%
10.42
0.00
Retained Earnings
-68.33
-134.79%
-29.10
-157.55%
-11.30
-4.91%
-10.77
Gains Losses Not Affecting Retained Earnings
-0.02
-103.86%
0.41
+0.73%
0.41
-39.11%
0.68
Other Equity Adjustments
-0.02
-103.86%
0.41
+0.73%
0.41
-39.11%
0.68
Total Equity Gross Minority Interest
-7.17
-5.55%
-6.79
-1386.43%
-0.46
+95.47%
-10.09
Total Capitalization
-7.17
-5.55%
-6.79
-1386.43%
-0.46
+94.46%
-8.25
Working Capital
-8.44
-5.17%
-8.03
-304.12%
3.93
+194.16%
-4.18
Invested Capital
-6.51
-1586.30%
0.44
-17.05%
0.53
+106.54%
-8.08
Total Debt
0.78
-89.61%
7.46
+657.06%
0.98
-51.00%
2.01
Net Debt
—
6.68
—
2.01
Capital Lease Obligations
0.12
-49.12%
0.23
0.00
—
Net Tangible Assets
-7.17
-5.55%
-6.79
-1386.43%
-0.46
+95.47%
-10.09
Tangible Book Value
-7.17
-5.55%
-6.79
-1386.43%
-0.46
+95.47%
-10.09
Current Notes Payable
0.00
-100.00%
0.57
+210.81%
0.18
—
Derivative Product Liabilities
0.00
-100.00%
0.14
-2.82%
0.14
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-15.55
-60.66%
-9.68
-25.33%
-7.72
-240.91%
-2.27
Cash Flow From Continuing Operating Activities
-15.55
-60.66%
-9.68
-25.33%
-7.72
-240.91%
-2.27
Net Income From Continuing Operations
-39.22
-120.33%
-17.80
-3227.48%
-0.54
+89.05%
-4.89
Depreciation Amortization Depletion
2.42
+430.63%
0.46
0.00
—
Depreciation
0.02
+110.00%
0.01
0.00
—
Amortization Cash Flow
2.40
+437.81%
0.45
0.00
—
Depreciation And Amortization
2.42
+430.63%
0.46
0.00
—
Amortization Of Intangibles
2.40
+437.81%
0.45
0.00
—
Other Non Cash Items
14.36
+383.28%
2.97
+199.60%
0.99
+274.34%
0.27
Stock Based Compensation
2.18
+33.76%
1.63
+720.10%
0.20
0.00
Provisionand Write Offof Assets
—
0.00
+100.00%
-0.24
-172.51%
0.33
Operating Gains Losses
-0.03
-100.91%
3.20
+156.91%
-5.62
-493.63%
1.43
Gain Loss On Investment Securities
0.27
-89.32%
2.48
+144.32%
-5.60
-491.74%
1.43
Net Foreign Currency Exchange Gain Loss
-0.02
-223.08%
0.01
+133.33%
-0.04
0.00
Change In Working Capital
4.73
+3428.87%
-0.14
+94.36%
-2.52
-522.15%
0.60
Change In Prepaid Assets
-4.06
-78.71%
-2.27
-129.60%
-0.99
0.00
Change In Payables And Accrued Expense
-0.68
-130.16%
2.25
+247.29%
-1.53
-354.74%
0.60
Change In Accrued Expense
-1.11
-208.16%
1.03
+158.99%
-1.75
-390.52%
0.60
Change In Payable
0.43
-64.57%
1.23
+469.77%
0.21
—
Change In Account Payable
0.43
-64.57%
1.23
+469.77%
0.21
0.00
Change In Other Working Capital
—
—
—
0.33
Change In Other Current Assets
—
0.00
-100.00%
0.01
+200.00%
-0.01
Change In Other Current Liabilities
9.47
+7736.29%
-0.12
0.00
—
Investing Cash Flow
-0.81
-1779.07%
-0.04
-105.93%
0.72
+496.17%
-0.18
Cash Flow From Continuing Investing Activities
-0.81
-1779.07%
-0.04
-105.93%
0.72
+496.17%
-0.18
Net PPE Purchase And Sale
-0.41
-694.12%
-0.05
0.00
—
Purchase Of PPE
-0.41
-694.12%
-0.05
0.00
—
Capital Expenditure
-2.40
-4611.76%
-0.05
—
—
Net Investment Purchase And Sale
0.00
-100.00%
0.01
-98.39%
0.50
+235.81%
0.15
Purchase Of Investment
0.00
+100.00%
-0.49
0.00
—
Sale Of Investment
0.00
-100.00%
0.50
+0.20%
0.50
+235.81%
0.15
Net Intangibles Purchase And Sale
-0.40
0.00
—
—
Purchase Of Intangibles
-2.00
0.00
—
—
Net Other Investing Changes
—
—
0.23
+168.88%
-0.33
Financing Cash Flow
17.42
+187.16%
6.07
-44.49%
10.93
+346.45%
2.45
Cash Flow From Continuing Financing Activities
17.42
+187.16%
6.07
-44.49%
10.93
+346.45%
2.45
Net Issuance Payments Of Debt
-2.17
-188.61%
2.45
+7.17%
2.29
+106.50%
1.11
Issuance Of Debt
0.00
-100.00%
3.23
+41.12%
2.29
+106.50%
1.11
Repayment Of Debt
-2.17
-179.77%
-0.78
0.00
—
Long Term Debt Issuance
—
—
2.29
+106.50%
1.11
Net Long Term Debt Issuance
—
—
2.29
+106.50%
1.11
Short Term Debt Issuance
0.00
-100.00%
3.23
+41.12%
2.29
—
Short Term Debt Payments
-2.17
-179.77%
-0.78
0.00
—
Net Short Term Debt Issuance
-2.17
-188.61%
2.45
+7.17%
2.29
—
Net Common Stock Issuance
19.59
+488.73%
3.33
0.00
-100.00%
1.34
Common Stock Payments
-0.11
0.00
—
—
Repurchase Of Capital Stock
-0.11
0.00
—
—
Proceeds From Stock Option Exercised
0.00
-100.00%
0.29
0.00
—
Net Other Financing Charges
—
—
8.64
—
Changes In Cash
1.06
+128.95%
-3.66
-193.10%
3.93
+393000.00%
-0.00
Effect Of Exchange Rate Changes
-0.10
-550.00%
-0.02
-105.35%
0.30
+29800.00%
0.00
Beginning Cash Position
0.55
-86.90%
4.23
0.00
0.00
End Cash Position
1.51
+172.38%
0.55
-86.90%
4.23
0.00
Free Cash Flow
-17.96
-84.51%
-9.73
-25.99%
-7.72
-240.91%
-2.27
Interest Paid Supplemental Data
0.00
-100.00%
0.08
-35.48%
0.12
0.00
Common Stock Issuance
19.70
+491.92%
3.33
0.00
-100.00%
1.34
Issuance Of Capital Stock
19.70
+491.92%
3.33
0.00
-100.00%
1.34
Sale Of Intangibles
1.59
0.00
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category